Ilyang Pharmaceutical Co.,Ltd (KOSE: A007570)
Health Care · Pharmaceuticals · KR
₩8,300.00
-4.49% today · -34.1% 1Y
Ilyang Pharmaceutical Co.,Ltd (KOSE: A007570) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $107.35M.
Over the last twelve months the share price has lost 34.1%, trading between 7.29K and 16.24K.
Tweenvest scores Ilyang Pharmaceutical Co.,Ltd across four factors: quality 59/100, value 66/100, growth 0/100, dividend 28/100. Its strongest factor is value.
A007570 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $107.35M
- Revenue (TTM)
- $179.49M
- P/E
- 8.41
- EPS
- 986.79
- Dividend yield
- 1.87%
- Beta (5Y)
- 0.38
- 52-week high
- ₩16,240.00
- 52-week low
- ₩7,290.00
- Avg volume (3M)
- —
- Shares outstanding
- 17.92M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.